Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) [Phase 2]

View source ↗

Summary

Phase 2 trial of balovaptan in autism spectrum disorder was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Balovaptan (balovaptan)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Autism Spectrum Disorder | Phase 2 | Status: TERMINATED | Results posted: 2021-02-08